The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.
Thorsten Simon
Children's Hospital
University of Cologne
Cologne
Germany
Name/email consistency: high
- Long term outcome of high-risk neuroblastoma patients after immunotherapy with antibody ch14.18 or oral metronomic chemotherapy. Simon, T., Hero, B., Faldum, A., Handgretinger, R., Schrappe, M., Klingebiel, T., Berthold, F. BMC. Cancer (2011)
- Treatment and outcomes of patients with relapsed, high-risk neuroblastoma: results of German trials. Simon, T., Berthold, F., Borkhardt, A., Kremens, B., De Carolis, B., Hero, B. Pediatr. Blood. Cancer (2011)
- Multiple malignant diseases in a patient with Rothmund-Thomson syndrome with RECQL4 mutations: Case report and literature review. Simon, T., Kohlhase, J., Wilhelm, C., Kochanek, M., De Carolis, B., Berthold, F. Am. J. Med. Genet. A (2010)
- Review of image defined risk factors in localized neuroblastoma patients: Results of the GPOH NB97 trial. Simon, T., Hero, B., Benz-Bohm, G., von Schweinitz, D., Berthold, F. Pediatr. Blood. Cancer (2008)
- Topotecan, cyclophosphamide, and etoposide (TCE) in the treatment of high-risk neuroblastoma. Results of a phase-II trial. Simon, T., Längler, A., Harnischmacher, U., Frühwald, M.C., Jorch, N., Claviez, A., Berthold, F., Hero, B. J. Cancer Res. Clin. Oncol. (2007)
- Topotecan and etoposide in the treatment of relapsed high-risk neuroblastoma: results of a phase 2 trial. Simon, T., Längler, A., Berthold, F., Klingebiel, T., Hero, B. J. Pediatr. Hematol. Oncol. (2007)
- Risk estimation in localized unresectable single copy MYCN neuroblastoma by the status of chromosomes 1p and 11q. Simon, T., Spitz, R., Hero, B., Berthold, F., Faldum, A. Cancer Lett. (2006)
- Intensified external-beam radiation therapy improves the outcome of stage 4 neuroblastoma in children > 1 year with residual local disease. Simon, T., Hero, B., Bongartz, R., Schmidt, M., Müller, R.P., Berthold, F. Strahlenther. Onkol (2006)
- Infants with stage 4 neuroblastoma: the impact of the chimeric anti-GD2-antibody ch14.18 consolidation therapy. Simon, T., Hero, B., Faldum, A., Handgretinger, R., Schrappe, M., Niethammer, D., Berthold, F. Klin. Padiatr (2005)
- Consolidation treatment with chimeric anti-GD2-antibody ch14.18 in children older than 1 year with metastatic neuroblastoma. Simon, T., Hero, B., Faldum, A., Handgretinger, R., Schrappe, M., Niethammer, D., Berthold, F. J. Clin. Oncol. (2004)
- New definition of low-risk neuroblastoma using stage, age, and 1p and MYCN status. Simon, T., Spitz, R., Faldum, A., Hero, B., Berthold, F. J. Pediatr. Hematol. Oncol. (2004)
